Risk-based pathway for outpatient penicillin allergy evaluations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk-based pathway for outpatient penicillin allergy evaluations

Published:2019-09 Issue:7 Volume:7 Page:2411-2414.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Blumenthal Kimberly G.,Huebner Emily M.,Fu Xiaoqing,Li Yu,Bhattacharya Gita,Levin Amy S.,Mancini Christian M.,Slawski Benjamin R.,Banerji Aleena

Funder

National Institutes of Health

American Academy of Allergy, Asthma, and Immunology Foundation

Massachusetts General Hospital

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference9 articles.

1. Antibiotic allergy;Blumenthal;Lancet,2019

2. Evaluation and management of penicillin allergy: a review;Shenoy;JAMA,2019

3. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children;Mill;JAMA Pediatr,2016

4. Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits;Tucker;J Allergy Clin Immunol Pract,2017

5. Penicillin allergy evaluation: a prospective, multicenter, open label evaluation of a comprehensive penicillin skin testing kit;Solensky;J Allergy Clin Immunol Pract,2019

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-Lactam allergy delabeling is safe and saves costs in Primary Care;Atención Primaria;2024-11

2. DxGoals: A Software Tool for Determining and Analyzing Clinically Meaningful Classification Accuracy Goals for Diagnostic Tests;The Journal of Applied Laboratory Medicine;2024-09

3. Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

4. Risk Stratification of Penicillin Allergy Labeled Children: A Cross-Sectional Study from Jordan;Therapeutics and Clinical Risk Management;2024-08

5. How to Define and Manage Low-Risk Drug Allergy Labels;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3